688580 伟思医疗
已收盘 12-16 15:00:00
资讯
新帖
简况
11月21日伟思医疗跌5.37%,北信瑞丰健康生活基金重仓该股
证券之星 · 11-21
11月21日伟思医疗跌5.37%,北信瑞丰健康生活基金重仓该股
每周股票复盘:伟思医疗(688580)股东减持117.68万股未完成原计划
证券之星 · 11-16
每周股票复盘:伟思医疗(688580)股东减持117.68万股未完成原计划
伟思医疗(688580)披露股东减持股份计划时间届满暨减持结果公告,11月12日股价上涨0.06%
证券之星 · 11-12
伟思医疗(688580)披露股东减持股份计划时间届满暨减持结果公告,11月12日股价上涨0.06%
每周股票复盘:伟思医疗(688580)股东减持72.82万股触及1%变动
证券之星 · 11-09
每周股票复盘:伟思医疗(688580)股东减持72.82万股触及1%变动
11月7日伟思医疗发生3笔大宗交易 成交金额993.29万元
证券之星 · 11-07
11月7日伟思医疗发生3笔大宗交易 成交金额993.29万元
【机构调研记录】汇泉基金调研伟思医疗、雷迪克等3只个股(附名单)
证券之星 · 10-29
【机构调研记录】汇泉基金调研伟思医疗、雷迪克等3只个股(附名单)
伟思医疗(688580)2025年三季报简析:营收净利润同比双双增长
证券之星 · 10-24
伟思医疗(688580)2025年三季报简析:营收净利润同比双双增长
伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%
智通财经 · 10-22
伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%
每周股票复盘:伟思医疗(688580)取消监事会并补选独董
证券之星 · 09-21
每周股票复盘:伟思医疗(688580)取消监事会并补选独董
每周股票复盘:伟思医疗(688580)陈莉莉减持7600股,成交额40.06万元
证券之星 · 09-07
每周股票复盘:伟思医疗(688580)陈莉莉减持7600股,成交额40.06万元
【机构调研记录】金元顺安基金调研伟思医疗
证券之星 · 09-03
【机构调研记录】金元顺安基金调研伟思医疗
伟思医疗:9月1日高管陈莉莉减持股份合计3200股
证券之星 · 09-02
伟思医疗:9月1日高管陈莉莉减持股份合计3200股
每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%
证券之星 · 08-31
每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%
伟思医疗(688580)6月30日股东户数0.81万户,较上期增加36.44%
证券之星 · 08-28
伟思医疗(688580)6月30日股东户数0.81万户,较上期增加36.44%
图解伟思医疗中报:第二季度单季净利润同比增长29.56%
证券之星 · 08-28
图解伟思医疗中报:第二季度单季净利润同比增长29.56%
每周股票复盘:伟思医疗(688580)董事减持3200股,股价上涨5.77%
证券之星 · 08-17
每周股票复盘:伟思医疗(688580)董事减持3200股,股价上涨5.77%
伟思医疗股价微涨0.25% 医疗设备板块整体承压
金融界 · 08-14
伟思医疗股价微涨0.25% 医疗设备板块整体承压
伟思医疗涨5.02% 脑机接口概念催化股价波动
智选洞察 · 08-12
伟思医疗涨5.02% 脑机接口概念催化股价波动
伟思医疗:8月7日高管陈莉莉减持股份合计3200股
证券之星 · 08-11
伟思医疗:8月7日高管陈莉莉减持股份合计3200股
医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道
加载更多
公司概况
公司名称:
南京伟思医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-07-21
主营业务:
南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、VisheeNEO生物刺激反馈仪、MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、Nd:YAG倍频皮秒激光治疗仪和科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤和一次性医用激光光纤。
发行价格:
67.58
{"stockData":{"symbol":"688580","market":"SH","secType":"STK","nameCN":"伟思医疗","latestPrice":43.9,"timestamp":1765868400000,"preClose":44.32,"halted":0,"volume":675898,"delay":0,"changeRate":-0.0095,"floatShares":95771299,"shares":95771299,"eps":1.3152,"marketStatus":"已收盘","change":-0.42,"latestTime":"12-16 15:00:00","open":44.2,"high":44.76,"low":43.69,"amount":29842900,"amplitude":0.0241,"askPrice":43.99,"askSize":13,"bidPrice":43.9,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.3152,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":44.32,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":48.75,"lowLimit":39.89,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":95771288,"isCdr":false,"pbRate":2.54,"roa":"--","peRate":33.378954,"roe":"6.17%","epsLYR":1.0685,"committee":-0.178571,"marketValue":4204000000,"turnoverRate":0.0071,"status":1,"afterMarket":{"amount":0,"volume":0,"close":43.9,"buyVolume":0,"sellVolume":0,"time":1765870437768,"indexStatus":"已收盘 12-16 15:30:00","preClose":44.32},"floatMarketCap":4204000000},"requestUrl":"/m/hq/s/688580","defaultTab":"news","newsList":[{"id":"2585419085","title":"11月21日伟思医疗跌5.37%,北信瑞丰健康生活基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585419085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585419085?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:48","pubTimestamp":1763711331,"startTime":"0","endTime":"0","summary":"证券之星消息,11月21日伟思医疗跌5.37%,收盘报43.34元,换手率1.44%,成交量1.38万手,成交额6104.38万元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为华银基金的北信瑞丰健康生活。北信瑞丰健康生活目前规模为0.9亿元,最新净值1.155,较上一交易日下跌0.94%,近一年上涨8.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100018798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2583965492","title":"每周股票复盘:伟思医疗(688580)股东减持117.68万股未完成原计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2583965492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583965492?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:49","pubTimestamp":1763239747,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,伟思医疗报收于47.9元,较上周的49.22元下跌2.68%。本周关注点股本股东变化:股东南京志达创业投资中心减持117.68万股,占总股本1.2287%。股本股东变化股东增减持11月12日伟思医疗发布公告,股东南京志达创业投资中心于2025年11月5日至11月11日间合计减持44.86万股,占公司目前总股本的0.4684%,变动期间该股股价下跌7.58%,截止11月11日收盘报48.17元。本次实际减持情况与此前披露的计划一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2582771093","title":"伟思医疗(688580)披露股东减持股份计划时间届满暨减持结果公告,11月12日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582771093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582771093?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:25","pubTimestamp":1762957524,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,伟思医疗报收于48.2元,较前一交易日上涨0.06%,最新总市值为46.16亿元。该股当日开盘48.3元,最高49.49元,最低47.93元,成交额达9160.83万元,换手率为1.97%。本次减持计划时间区间已届满,未完成原定减持计划,当前持股比例由8.29%降至7.06%。本次实际减持情况与此前披露的计划一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2582869509","title":"每周股票复盘:伟思医疗(688580)股东减持72.82万股触及1%变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2582869509","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582869509?lang=zh_cn&edition=full","pubTime":"2025-11-09 02:34","pubTimestamp":1762626855,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,伟思医疗报收于49.22元,较上周的54.13元下跌9.07%。来自公司公告汇总:控股股东及其一致行动人合计持股比例由47.74%降至46.98%。交易信息汇总11月7日伟思医疗发生3笔大宗交易,成交金额993.29万元。股本股东变化股东增减持11月4日伟思医疗发布公告,股东南京志达创业投资中心于2025年8月14日至2025年11月4日间合计减持72.82万股,占公司目前总股本的0.7604%,变动期间该股股价下跌6.93%,截止11月4日收盘报52.12元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2581008419","title":"11月7日伟思医疗发生3笔大宗交易 成交金额993.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581008419","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581008419?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:21","pubTimestamp":1762507272,"startTime":"0","endTime":"0","summary":"证券之星消息,11月7日伟思医疗发生大宗交易,交易数据如下:近三个月该股共发生3笔大宗交易,合计成交2207.0手,折价成交3笔。该股近期无解禁股上市。截至2025年11月7日收盘,伟思医疗报收于49.22元,下跌2.46%,换手率1.62%,成交量1.55万手,成交额7717.03万元。该股近半年内有股东持股变动,合计净减持72.82万股,股东增减持明细如下表:该股最近90天内共有7家机构给出评级,买入评级5家,增持评级2家;过去90天内机构目标均价为60.0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700027549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2579291463","title":"【机构调研记录】汇泉基金调研伟思医疗、雷迪克等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579291463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579291463?lang=zh_cn&edition=full","pubTime":"2025-10-29 08:06","pubTimestamp":1761696388,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月28日披露的机构调研信息,汇泉基金近期对3家上市公司进行了调研,相关名单如下:1)伟思医疗 个股亮点:公司的下肢外骨骼装置进入医保目录;公司电刺激类产品,主要包括 MyOnyx 生物刺激反馈仪、瑞翼生物刺激反馈仪等,主要应用于妇产相关科室2)雷迪克 调研纪要:截至2025年第三季度末,公司营收达80,543.94万元,同比增长56.52%;净利润13,765.78万元,同比增长48.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900012533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580","BK0264","300652"],"gpt_icon":0},{"id":"2577588537","title":"伟思医疗(688580)2025年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2577588537","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577588537?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:03","pubTimestamp":1761256982,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期伟思医疗发布2025年三季报。根据财报显示,伟思医疗营收净利润同比双双增长。截至本报告期末,公司营业总收入3.26亿元,同比上升11.58%,归母净利润1.02亿元,同比上升30.68%。按单季度数据看,第三季度营业总收入1.15亿元,同比上升14.87%,第三季度归母净利润3282.4万元,同比上升14.99%。去年的净利率为25.49%,算上全部成本后,公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580"],"gpt_icon":0},{"id":"2577666352","title":"伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577666352","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577666352?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:31","pubTimestamp":1761125460,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)披露2025年第三季度报告,公司前三季度实现营收3.26亿元,同比增长11.58%;归属于上市公司股东的净利润1.02亿元,同比增长30.68%;扣非净利润9360万元,同比增长37.35%;基本每股收益1.07元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580"],"gpt_icon":0},{"id":"2569246317","title":"每周股票复盘:伟思医疗(688580)取消监事会并补选独董","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246317","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246317?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:01","pubTimestamp":1758398479,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,伟思医疗报收于49.55元,较上周的50.88元下跌2.61%。本周,伟思医疗9月18日盘中最高价报52.98元。本周关注点公司公告汇总:伟思医疗召开2025年第一次临时股东大会,审议通过取消监事会、修订公司章程等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2565546881","title":"每周股票复盘:伟思医疗(688580)陈莉莉减持7600股,成交额40.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565546881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565546881?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:07","pubTimestamp":1757200032,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,伟思医疗报收于51.6元,较上周的52.96元下跌2.57%。本周,伟思医疗9月1日盘中最高价报53.79元。本周关注点股本股东变化:董事陈莉莉减持3200股,占总股本0.0033%。公司公告汇总:陈莉莉减持7600股,成交额40.06万元,持股降至23025股。陈莉莉减持前持有30,625股,通过集中竞价减持7,600股,价格区间为48.40~53.46元/股,减持金额400,620.80元,当前持股23,025股。减持期间为2025年6月3日至9月3日,实际减持与披露计划一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2564334597","title":"【机构调研记录】金元顺安基金调研伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2564334597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564334597?lang=zh_cn&edition=full","pubTime":"2025-09-03 08:03","pubTimestamp":1756857818,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为金元顺安产业臻选混合A,最新单位净值为0.9,近一年增长63.4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300005647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2564385802","title":"伟思医疗:9月1日高管陈莉莉减持股份合计3200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564385802","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564385802?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:04","pubTimestamp":1756814662,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月2日市场公开信息、上市公司公告及交易所披露数据整理,伟思医疗最新董监高及相关人员股份变动情况:2025年9月1日公司董事,高级管理人员陈莉莉共减持公司股份3200.0股,占公司总股本为0.0033%。变动期间公司股价上涨1.17%,9月1日当日收盘报53.58元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200036002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2563383640","title":"每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563383640","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563383640?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:29","pubTimestamp":1756607348,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘,伟思医疗报收于52.96元,较上周的54.72元下跌3.22%。本周,伟思医疗8月26日盘中最高价报56.56元。业绩披露要点:2025年中报归母净利润6932.42万元,同比上升39.71%。股本股东变化股东户数变动截至2025年6月30日,伟思医疗股东户数为8095.0户,较3月31日增加2162.0户,增幅36.44%。2025年第二季度单季度主营收入1.15亿元,同比上升10.23%;单季度归母净利润3610.42万元,同比上升29.56%;单季度扣非净利润3303.3万元,同比上升36.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2562082607","title":"伟思医疗(688580)6月30日股东户数0.81万户,较上期增加36.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562082607","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562082607?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:28","pubTimestamp":1756373314,"startTime":"0","endTime":"0","summary":"在医疗器械行业个股中,伟思医疗股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.21万户。从股价来看,2025年3月31日至2025年6月30日,伟思医疗区间涨幅为39.47%,在此期间股东户数增加2162.0户,增幅为36.44%。根据统计,伟思医疗2025年3月31日至2025年6月30日,主力资金净流出1.87亿元,游资资金净流入1.4亿元,散户资金净流入4792.44万元。期间龙虎榜该股共上榜4次。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800033226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2562729013","title":"图解伟思医疗中报:第二季度单季净利润同比增长29.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562729013","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562729013?lang=zh_cn&edition=full","pubTime":"2025-08-28 01:43","pubTimestamp":1756316629,"startTime":"0","endTime":"0","summary":"证券之星消息,伟思医疗2025年中报显示,公司主营收入2.1亿元,同比上升9.85%;归母净利润6932.42万元,同比上升39.71%;扣非净利润6357.13万元,同比上升46.3%;其中2025年第二季度,公司单季度主营收入1.15亿元,同比上升10.23%;单季度归母净利润3610.42万元,同比上升29.56%;单季度扣非净利润3303.3万元,同比上升36.27%;负债率8.95%,投资收益659.32万元,财务费用-190.48万元,毛利率66.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800001483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580"],"gpt_icon":0},{"id":"2560992504","title":"每周股票复盘:伟思医疗(688580)董事减持3200股,股价上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560992504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560992504?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:36","pubTimestamp":1755376573,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘,伟思医疗报收于55.51元,较上周的52.73元上涨5.27%。本周,伟思医疗8月13日盘中最高价报57.3元。8月11日盘中最低价报51.71元。伟思医疗当前最新总市值53.16亿元,在医疗器械板块市值排名72/126,在两市A股市值排名3115/5152。变动期间公司股价上涨5.77%,8月7日当日收盘报53.55元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2559983294","title":"伟思医疗股价微涨0.25% 医疗设备板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2559983294","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559983294?lang=zh_cn&edition=full","pubTime":"2025-08-14 00:13","pubTimestamp":1755101609,"startTime":"0","endTime":"0","summary":"伟思医疗8月13日股价报收56.00元,较前一交易日上涨0.14元,涨幅0.25%。当日成交量为48657手,成交金额达2.7亿元,换手率为5.08%。伟思医疗属于医疗器械板块,公司主营业务为医疗设备的研发、生产和销售。公司产品涵盖多个医疗领域,包括康复医疗设备、手术器械等。从资金流向来看,伟思医疗8月13日主力资金净流出1459.31万元,近五日累计净流出888.30万元。当日医疗设备板块整体表现不佳,多只相关个股出现下跌。风险提示:股市有风险,投资需谨慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/14001352414251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","159873","688580"],"gpt_icon":0},{"id":"2558327697","title":"伟思医疗涨5.02% 脑机接口概念催化股价波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2558327697","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558327697?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:49","pubTimestamp":1754963371,"startTime":"0","endTime":"0","summary":"伟思医疗股价今日大幅上涨,最新价为55.66元/股,涨幅达5.02%。多重因素共振引发股价波动伟思医疗近期的股价波动与脑机接口概念催化密切相关。但板块轮动效应同样显著,8月4日医疗器械板块振幅达5.21%,电子、通信赛道分流资金导致单日净流出388.7万元。政策端康复医疗纳入医保试点已扩至12省,湖北等地脑机接口收费标准落地,中信证券给予52元目标价对应估值修复空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812094940a6e092b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812094940a6e092b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2558650662","title":"伟思医疗:8月7日高管陈莉莉减持股份合计3200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2558650662","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558650662?lang=zh_cn&edition=full","pubTime":"2025-08-11 20:02","pubTimestamp":1754913739,"startTime":"0","endTime":"0","summary":"证券之星消息,根据8月11日市场公开信息、上市公司公告及交易所披露数据整理,伟思医疗最新董监高及相关人员股份变动情况:2025年8月7日公司董事,高级管理人员陈莉莉共减持公司股份3200.0股,占公司总股本为0.0033%。变动期间公司股价上涨5.77%,8月7日当日收盘报53.55元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081100035400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持,行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高,支持性政策在产品注册、医保支付、行业标准等层面均有体现。1)在产品注册方面,国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策,脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","688301","688351","688068","688426","603658","688193","688314","600529","688677","688085","688755","600587","688410","600807","688613","603014","688656","600645","603987","605369","688393","688277","688298","688576","688767","688198","688026","688075","688366","603880","688253","688389","688606","560260","688581","688617","688468","603222","603205","603976","688212","688139","688050","688013","603309","688217","159883","688161","688575","688317","688338","688151","688607","603387","688108","688114","688358","688236","688029","688289","688271","688016","688273","688067","600055"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765899769690,"stockEarnings":[{"period":"1week","weight":-0.0323},{"period":"1month","weight":-0.0747},{"period":"3month","weight":-0.1506},{"period":"6month","weight":-0.0234},{"period":"1year","weight":0.3792},{"period":"ytd","weight":0.6159}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京伟思医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"8098人(较上一季度增加0.04%)","perCapita":"11826股","listingDate":"2020-07-21","address":"江苏省南京市雨花台区宁双路19号9栋","registeredCapital":"9577万元","survey":" 南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、VisheeNEO生物刺激反馈仪、MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、Nd:YAG倍频皮秒激光治疗仪和科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤和一次性医用激光光纤。","listedPrice":67.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伟思医疗,688580,伟思医疗股票,伟思医疗股票老虎,伟思医疗股票老虎国际,伟思医疗行情,伟思医疗股票行情,伟思医疗股价,伟思医疗股市,伟思医疗股票价格,伟思医疗股票交易,伟思医疗股票购买,伟思医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}